floxuridine has been researched along with Retroperitoneal Neoplasms in 3 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Retroperitoneal Neoplasms: New abnormal growth of tissue in the RETROPERITONEAL SPACE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 42 patients with metastatic renal cell carcinoma received floxuridine infusion for 14 days at monthly intervals." | 1.28 | Circadian infusion of floxuridine in patients with metastatic renal cell carcinoma. ( Amato, R; Dexeus, FH; Kilbourn, R; Kwan, J; Logothetis, CJ; Newman, RA; Ogden, S; Sella, A; Striegel, A, 1991) |
| "The authors treated 42 metastatic renal cell carcinoma (RCC) patients who had received no previous chemotherapy or radiation therapy with circadian venous continuous infusion of 5-fluoro-2-deoxyuridine (FUDR)." | 1.28 | Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump. ( Bonalumi, MG; Comeri, G; Damascelli, B; Del Nero, A; Garbagnati, F; Lutman, R; Marchianò, A; Mauri, M; Salvetti, M; Spreafico, C, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, Y | 1 |
| Itoyanagi, H | 1 |
| Saegusa, Y | 1 |
| Hasumi, K | 1 |
| Eriguchi, M | 1 |
| Dexeus, FH | 1 |
| Logothetis, CJ | 1 |
| Sella, A | 1 |
| Amato, R | 1 |
| Kilbourn, R | 1 |
| Ogden, S | 1 |
| Striegel, A | 1 |
| Kwan, J | 1 |
| Newman, RA | 1 |
| Damascelli, B | 1 |
| Marchianò, A | 1 |
| Spreafico, C | 1 |
| Lutman, R | 1 |
| Salvetti, M | 1 |
| Bonalumi, MG | 1 |
| Mauri, M | 1 |
| Garbagnati, F | 1 |
| Del Nero, A | 1 |
| Comeri, G | 1 |
3 other studies available for floxuridine and Retroperitoneal Neoplasms
| Article | Year |
|---|---|
[Effects of 5'-DFUR against BALB/c retroperitoneal sarcoma with spontaneous liver metastases].
Topics: Animals; Antineoplastic Agents; Female; Floxuridine; Liver Neoplasms, Experimental; Mice; Mice, Inbr | 1994 |
Circadian infusion of floxuridine in patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Renal Cell; Drug Administration Schedule; Female; Floxuridine; Humans; Infus | 1991 |
Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump.
Topics: Adult; Aged; Carcinoma, Renal Cell; Drug Evaluation; Female; Floxuridine; Humans; Infusion Pumps, Im | 1990 |